TechBio Founders #3: Treating mental illness: The Power of Psychedelics with Sam Banister, CSO Psylo episode artwork

EPISODE · Dec 28, 2022 · 31 MIN

TechBio Founders #3: Treating mental illness: The Power of Psychedelics with Sam Banister, CSO Psylo

from Next Sequence · host Loretta TIOIELA

Psylo is a drug development company focused on next generation psychedelics; Their goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. They are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.

Episode metadata supplied by the publisher feed · Published Dec 28, 2022

Embed this episode

NOW PLAYING

TechBio Founders #3: Treating mental illness: The Power of Psychedelics with Sam Banister, CSO Psylo

0:00 31:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 31 minutes long.

When was this Next Sequence episode published?

This episode was published on December 28, 2022.

Can I download this Next Sequence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!